Cogent Biosciences, Inc. Shares Issued
Cogent Biosciences, Inc. (COGT) had Shares Issued of 171.60 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-10
- 2026-06-30: Common Stock, Shares, Issued 171.60M shares.
- 2026-03-31: Common Stock, Shares, Issued 170.77M shares.
- 2025-12-31: Common Stock, Shares, Issued 160.98M shares.
- 2025-09-30: Common Stock, Shares, Issued 139.83M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 171.60M shares 10-Q · filed 2026-08-10 | |
| 2026-03-31 | 170.77M shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 160.98M shares 10-Q · filed 2026-08-10 | |
| 2025-09-30 | 139.83M shares 10-Q · filed 2025-11-07 | |
| 2025-06-30 | 113.93M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 113.86M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 110.46M shares 10-K · filed 2026-02-17 | |
| 2024-09-30 | 110.46M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 109.34M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 95.61M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 86.12M shares 10-K · filed 2025-02-25 | |
| 2023-09-30 | 86.12M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 85.33M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 70.95M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 69.89M shares 10-K · filed 2024-02-26 | |
| 2022-09-30 | 69.86M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 65.71M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 45.82M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 43.81M shares 10-K · filed 2023-03-14 | |
| 2021-09-30 | 39.85M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 39.83M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 37.19M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 32.35M shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 10.68M shares 10-Q · filed 2020-11-09 | |
| 2020-09-22 | 42.39M shares 10-K · filed 2022-03-15 | |
| 2020-06-30 | 31.16M shares 10-Q · filed 2020-08-11 | |
| 2020-03-31 | 30.82M shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 7.67M shares 10-K · filed 2021-03-16 | 30.66M shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 30.66M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 30.66M shares 10-Q · filed 2019-08-12 | |
| 2019-03-31 | 30.12M shares 10-Q · filed 2019-05-13 | |
| 2018-12-31 | 30.06M shares 10-K · filed 2020-03-26 | |
| 2018-09-30 | 29.92M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 29.87M shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 10.21M shares 10-Q · filed 2018-05-14 | |
| 2017-12-31 | 10.20M shares 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |